StemCell Therapy

Photo (c) loooby - Getty ImagesIncluding plenty of fruits and vegetables in your diet can help keep you healthy, but a recent study shows that one particular type of fruit could be more beneficial than previously thought.

Researchers from Western University say that a molecule called nobiletin that is found in oranges and tangerines can help reverse negative symptoms linked to obesity, heart disease, and diabetes. The team believes that their findings could be good news for health care providers who are always looking for new ways to promote better health.

"Obesity and its resulting metabolic syndromes are a huge burden to our health care system, and we have very few interventions that have been shown to work effectively," said Dr. Murray Huff. "We need to continue this emphasis on the discovery of new therapeutics."

The researchers came to their conclusions after studying mice who were fed a diet high in fat and cholesterol. While some of the mice were only given foods high in these substances, others were also given nobiletin.

After observing the physical changes in the mice over time, the team concluded that the mice that also received nobiletin were leaner and had lower levels of insulin resistance and blood fats when compared to the control mice. Huff says that these results strongly suggest that nobiletin can be used as a health intervention.

We've shown that in mice that already have all the negative symptoms of obesity, we can use nobiletin to reverse those symptoms, and even start to regress plaque build-up in the arteries, known as atherosclerosis, he said.

The team hopes to continue their research with human trials to see if nobiletin has the same effect on people. The full study has been published in the Journal of Lipid Research.

The rest is here:
Eating oranges and tangerines can help reduce risk of obesity, heart disease, and diabetes - ConsumerAffairs

People with diabetes are at high risk for kidney disease, but there are steps they can take to protect their kidneys.

Meda E. Pavkov, MD, PhD, medical epidemiologist in the Chronic Kidney Disease Initiative within the Division for Diabetes Translation at the Centers for Disease Control and Prevention (CDC), is a co-author of the Kidney Disease in Diabetes chapter in the NIDDK publication Diabetes in America, 3rd Edition. Here, she discusses the link between diabetes and kidney disease and the importance of early detection and management of kidney disease.

Q: What is the link between diabetes and kidney disease?

A: Diabetes is the most frequent cause of chronic kidney disease, not only in the United States but in most industrialized countries. Kidney disease in people with diabetes is caused by multiple factors, including diabetic changes in the kidneys as well as vascular changes due to hypertension. People with diabetes have high glycemia, or blood glucose, which can damage the kidneys and lead to kidney disease.

When people are diagnosed with diabetes, they may already have hypertension. Hypertension is an additional risk factor for diabetic kidney disease because high blood pressure damages the kidneys, which may prevent proper function.

Q: What are the benefits of talking about kidney disease risk factors with patients who have diabetes?

A: Most of the risk factors for kidney disease in patients with diabetes can be modified. We can treat and manage them. However, like many other chronic diseases, kidney disease has very few early symptoms. For instance, a patient may have albuminuria, which is the earliest sign of kidney disease. It means that there is too much of the protein albumin in the urine, but a patient may not have any symptoms specific to the albuminuria.

The prevalence of kidney disease in the United States is about 15 percent, yet awareness of kidney disease is very low. Patients can have kidney disease for a long time without having symptoms or knowing that they have the disease. We found that many transplant patients and new dialysis patients had little awareness of their kidney disease and did not know what they could have done to help prevent or slow the disease before kidney failure.

It is especially important to talk to patients with diabetes about kidney disease risk factors because they are more than twice as likely to develop kidney disease than those without diabetes. By talking with patients who have diabetes about kidney disease, the disease may be diagnosed early, and patients can take steps to help slow its progression.

Q: Why is it so important to diagnose kidney disease in patients with diabetes as early as possible?

A: By diagnosing kidney disease as early as possible, we can treat the disease earlier, which means slowing disease progression. The end goal for treating kidney disease as early as possible is to prevent kidney failure, which is when the kidneys have lost most of their ability to function. By preventing kidney failure, you avoid end-stage renal disease, which is the stage at which dialysis or a kidney transplant is needed to survive.

Patients with diabetes who know they have kidney disease can

Diagnosing and managing kidney disease early can prevent complications, particularly cardiovascular complications. Many physicians and researchers are not aware that among people with diabetes, kidney disease doubles the risk for cardiovascular disease.

Beyond the positive health implications of diagnosing and treating kidney disease early, CDC has published studies demonstrating that diagnosing and treating the disease early to avoid kidney failure and other complications is cost effective.

Q: What are the recommended guidelines for kidney disease testing?

A: Kidney disease is diagnosed and tracked using two tests. One is a blood test, called serum creatinine, used to calculate the glomerular filtration rate (GFR), or kidney function, which assesses how well the kidneys are filtering blood. A GFR below 60 for at least 3 months indicates chronic kidney disease.

The other test used to diagnose and monitor kidney disease checks for albumin in the urine. Anyone with a urine albumin result above 30 milligrams per gram for at least two out of three albumin tests in a 3-month period is considered to have kidney disease. Physicians should be aware of the importance of the urine albumin test, because it is able to detect early kidney disease.

Guidelines recommend that anyone with one or more risk factors for kidney diseasepeople with diabetes, hypertension, or heart disease; those with a family history of kidney disease or diabetes; people older than 50 years; and those who smokebe tested for kidney disease. Testing for kidney disease is inexpensive and easy and is critical to identifying and treating the disease early.

Q: How can health care professionals help to prevent or slow kidney disease from progressing in patients with diabetes?

A: Its important for health care professionals to educate patients about their risk for kidney disease, how the disease might affect their health, what they need to avoid, and how they can modify their lifestyle to prevent or slow the disease. When patients understand their risks, they may be more likely to talk with their health care professional about getting tested for kidney disease and more aware of the importance of keeping their kidneys healthy.

In general, kidney disease progresses relatively slowly with few or no symptoms, so there is a very long window of opportunity to personalize and adjust treatment to a patient's situation. The first and most important way to prevent or slow kidney disease in people with diabetes, whether its type 1 or type 2 diabetes, is to manage blood glucose levels. Glucose levels should be monitored regularly. Another way to help prevent or slow kidney disease progression is by managing blood pressure. This is particularly important in patients with type 2 diabetes, who often have high blood pressure. Lifestyle changes and medications such as ARBs, or angiotensin receptor blockers, often play a key role in controlling blood pressure in people with diabetes.

Ultimately, the best way to prevent kidney disease is to prevent type 2 diabetes, because nearly 40 percent of people with diabetes will develop kidney disease.

Q: Is there anything else that health care professionals should know about kidney disease in people with diabetes?

A: The U.S. Department of Health and Human Services recently announced an important new kidney disease initiative called Advancing American Kidney Health. The initiative has three main goalsto reduce the number of Americans developing kidney failure, encourage home dialysis rather than treatment in dialysis centers, and increase the number of kidneys available for transplant.

This initiative is exciting because it recognizes kidney disease as an important public health issue and creates an official policy framework to improve kidney care in the United States. It aims to improve prevention and treatment, redesign dialysis to improve the quality of life among dialysis patients and increase their life expectancies, and create incentives for individuals to donate kidneys.

Continued here:
The Link Between Diabetes and Kidney Disease - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Published: March, 2020

As we've reported before, eating or drinking heavily processed foods like sugary drinks, chicken nuggets, frozen dinners, or sweetened cereals is associated with an increased risk for weight gain, heart disease, and even early death. Now a large observational study published online Dec. 16, 2019, by JAMA Internal Medicine links the consumption of such "ultraprocessed" food to an increased risk for developing diabetes. Researchers evaluated the questionnaire responses of more than 100,000 diabetes-free people (average age about 43) over six years. People who ate the most ultraprocessed foods (about 22% of their diet) had a higher risk for developing diabetes compared with people who ate the least amount of ultraprocessed foods (about 11% of their diet). The risk for developing diabetes went up 15% for a 10-percentage-point increase in the amount of ultraprocessed food in the diet. The connection held up even after scientists accounted for known risk factors for diabetes, such as weight and physical activity. The takeaway: Skip processed foods in favor of whole foods, including lots of vegetables, fruits, legumes, and whole grains.

Image: Jamesmcq24/Getty Images

Disclaimer:As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.

See more here:
Heavily processed foods tied to diabetes - Harvard Health

Global Diabetic Footwear Market, By Product (Slippers, Sandals and Shoes), By End User (Women and Men), By Distribution Channel (Store-based Vs. Non-store based), By Region, Competition, Forecast & Opportunities, 2025.

New York, March 06, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Diabetic Footwear Market, By Product, By End User, By Distribution Channel, By Region, Competition, Forecast & Opportunities, 2025" - https://www.reportlinker.com/p05872172/?utm_source=GNW

Global diabetic footwear market is projected to reach $ 9.7 billion by 2025 on account of rising adoption of diabetic footwear as they are designed to minimize the risk of skin breakdown caused by poor circulation, neuropathy and foot deformities. Moreover, these footwears offer a variety of features like non-binding uppers, stretchable uppers, orthotic support, extra depth design for a pressure-free fit, deep-toe-box, functional soles, and others in order to protect diabetic feet. These designed footwears are mostly used by athletes and common people that are suffering from foot deformities caused by diabetes. Diabetes leads to poor control over blood sugar levels and thus can damage nerves and vessels of feet. Therefore, consumers with diabetes are more likely to have foot problems which are the key factor anticipated to influence the demand for diabetic footwear across the globe in the coming years. Rising prevalence of diabetes and growing disposable income are some of the major factors anticipated to propel the global diabetic footwear market in the coming years. However, the market growth is likely to be negatively affected on account of lack of proper knowledge about using diabetic footwear among potential users as well as low awareness about proper foot care in diabetic patients, particularly in underdeveloped and developing countries. The global diabetic footwear market is segmented based on the product, end-user, distribution channel and region.Based on the product, the market can be segmented into slippers, sandals and shoes.

Among them, the shoe footwear type dominated the market in 2019, and the product segment is expected to maintain its leadership position in the coming years as well which can be attributed to the higher preference of shoes in both men and women. Office going population always prefers wearing shoes since a formal attire includes shoe, which is increasing the demand for these shoes, thereby boosting the growth of this segment in the market. Major players operating in the diabetic footwear market are Podartis S.r.l., American Aetrex Worldwide, Inc., Orthofeet Inc, Drew Shoes (U.S.), Dr. Comfort, DJO Global Inc (U.S.), Dr. Zen Products, Inc. (U.S.), Propet USA, Inc. (U.S.), DARCO International, I-Runner (U.S.), Finn Comfort (U.S.), Pilgrim shoes (U.S.), Hush Puppies Retail, Inc., New Balance, Inc., and others.

Years considered for this report:

Historical Years: 2015-2018 Base Year: 2018 Estimated Year: 2019 Forecast Period: 20202025

Objective of the Study:

To analyze and forecast the market size of the global diabetic footwear market. To classify and forecast global diabetic footwear market based on the product, end-user, distribution channel, company and regional distribution. To identify drivers and challenges for the global diabetic footwear market. To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the global diabetic footwear market. To conduct a pricing analysis for the global diabetic footwear market. To identify and analyze the profile of leading players operating in the global diabetic footwear market. The analyst performed both primary as well as exhaustive secondary research for this study.Initially, the analyst sourced a list of diabetic footwear manufacturers across the globe.

Subsequently, the analyst conducted primary research surveys with the identified companies.While interviewing, the respondents were also enquired about their competitors.

Through this technique, the analyst could include the manufacturers which could not be identified due to the limitations of secondary research. The analyst examined the distribution channels and presence of all major players across the globe. The analyst calculated the market size of global diabetic footwear market by using a bottom-up approach, wherein data for various end-user segments were recorded and forecast for the future years. The analyst sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size.

Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the analyst.

Key Target Audience:

Diabetic footwear manufacturers, suppliers and other stakeholders Government bodies such as regulating authorities and policymakers Organizations, forums and alliances related to diabetic footwear Market research and consulting firms The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, the global diabetic footwear market has been segmented into the following categories, in addition to the industry trends which have also been detailed below: Market, By Product: o Shoes o Sandals o Slippers Market, By End User: o Men o Women Market, By Distribution Channel: o Store-based o Non-store based Market, By Region: o North America United States Mexico Canada o Asia-Pacific China Japan India South Korea Australia o Europe Germany France United Kingdom Italy Spain o South America Brazil Colombia Argentina o Middle East & Africa South Africa Saudi Arabia UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the global diabetic footwear market.

Available Customizations:

With the given market data, we offers customizations according to a companys specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).Read the full report: https://www.reportlinker.com/p05872172/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Story continues

Clare: clare@reportlinker.comUS: (339)-368-6001Intl: +1 339-368-6001

Read more:
Global diabetic footwear market is projected to reach $ 9.7 billion by 2025 - Yahoo Finance

Diabetic foot ulcers continue to be a major cause of morbidity and mortality in patients with diabetes despite several standard of care options. A paper published in the American Journal of Clinical Dermatology highlights new trends in the management of diabetic foot ulcers, including the use of adjunctive therapies.

Pressure relief, debridement, infection management, and revascularization comprise the current gold standard of care for diabetic foot ulcers. Despite the potential benefit of each component, this regimen alone may not be sufficient for the prevention and management of foot ulcers in patients with diabetes. Although prevention is key, new trends in diabetes foot ulcer management have been shown to greatly improve treatment beyond current standard of care.

For ulcers that persist beyond the 4-week standard of care treatment recommendation, adjunctive approaches may be an option. Negative pressure wound therapy, for instance, may potentially assist in promoting wound healing via the application of intermittent or continuous negative pressure to a wound. Hyperbaric oxygen therapy is another adjunctive approach that has been suggested for diabetic foot ulcers; however, the efficacy of this strategy is considered controversial, according to the published literature.

There is an increasing trend toward the use of bioengineered skin substitutes as adjunct therapy for treating and closing diabetic foot ulcer wounds. Skin substitutes used for diabetic foot ulcers include dermal substitutes consisting of either acellular or cellular extracellular matrix and composite substitutes of dermal and epidermal components. In addition, a growing trend has been observed in the use of topical growth factors for diabetic foot ulcers.

There is currently only 1 topical recombinant human platelet-derived growth factor approved by the US Food and Drug Administration for the treatment of foot ulcers in patients with diabetes. The product may be more cost effective compared with standard of care alone. Although promising, high doses of this adjunctive approach have been linked to an increased risk for cancer.

Electrical stimulation is another emerging technologic approach for treatment of hard to treat foot ulcer wounds. Evidence to support this strategy is mostly found in individual case reports and small studies. The newest trend in diabetic foot ulcer adjunctive therapy pressure and temperature feedback devices is increasingly used in foot ulcer prevention strategies in patients with diabetic peripheral neuropathy.

Although many of the emerging approaches are novel and most lack sufficient evidence to support their clinical efficacy, the investigators wrote that the new standard of care for the management of diabetic foot ulcers should integrate a multimodal approach that addresses the many factors that contribute to ulcer development as well as those that promote wound healing.

Follow @EndoAdvisor

Reference

Aldana PC, Khachemoune A. Diabetic foot ulcers: appraising standard of care and reviewing new trends in management [published online December 17, 2019]. Am J Clin Dermatol. doi:10.1007/s40257-019-00495-x

This article originally appeared on Dermatology Advisor

View original post here:
Prevention and Treatment of Diabetic Foot Ulcers May Benefit From Multimodal Approach - Endocrinology Advisor

New research has found that brushing teeth three times a day could lower an individual's risk of diabetes, while neglecting oral hygiene could actually increase the risk.

Carried out by researchers at Seoul Hospital and Ewha Woman's University College of Medicine, Seoul, South Korea, the new study looked at data gathered from 188,013 subjects who had provided information on their past medical history, oral hygiene behaviors, such as the number of times they brushed their teeth each day, how often they went to the dentist, and how often they had their teeth professionally cleaned and their number of missing teeth.

The findings, published in the journalDiabetologia, showed that after taking into account possible influencing factors such as age, sex, weight, height and blood pressure, brushing teeth three times a day or more is linked to an 8 percent lower risk of developing diabetes.

On the other hand, individuals with dental disease had a 9 percent higher risk of developing diabetes, and those with numerous teeth missing (15 or more) had a 21 percent higher risk.

The researchers also found that diabetes risk differed by age and gender.

For the participants age 51 and younger, brushing twice a day was linked to a 10 percent reduced risk of developing diabetes compared with those who brushed once a day or not at all, while brushing teeth three times a day reduced the risk by 14 percent.

However, for those aged 52 and older, it made no difference whether the participants brushed twice a day, once a day, or not at all there was no difference in diabetes risk unless the participants brushed three or more times per day, which was linked with a 7 percent decreased risk.

Read also: You do it at least twice a day, but are you brushing your teeth right?

Periodontal disease also increased the risk of diabetes by 14 percent for younger adults, whereas in the older group the increased risk was just 6 percent.

There were also stronger associations between increasing brushing and reduced diabetes risk in women. For women, brushing two or three times per day was linked with an 8 and 15 percent reduced risk, respectively, of developing diabetes, whereas for men, there was only a 5 percent reduction in risk of diabetes for those brushing three times or more per day, and no statistically significant difference in risk between brushing twice a day, once a day or not at all.

The researchers point out that the study does not explain how exactly oral hygiene could lead to the development of diabetes, however, they add that tooth decay can contribute to chronic and systemic inflammation, and inflammation has been found in previous studies to be linked to diabetes.

They conclude that, Frequent tooth brushing may decrease the risk of new-onset diabetes, and the presence of periodontal disease and increased number of missing teeth may increase that risk. Overall, improving oral hygiene may be associated with a decreased risk of occurrence of new-onset diabetes.

Your premium period will expire in 0 day(s)

Subscribe to get unlimited access Get 50% off now

Read more:
Brushing teeth three times a day could lower the risk of diabetes - The Jakarta Post - Jakarta Post

Home Topics Diabetes Type 2 Diabetes

Potent topical corticosteroids should be used sparingly, and screening for type 2 diabetes should continue to be a routine part of chronic disease prevention and management, according to a critical appraisal published in the British Journal of Dermatology.1

Although topical corticosteroids are widely used to treat inflammatory or pruritic skin conditions, the impact of their systemic absorption on the risk for hyperglycemia and subsequent type 2 diabetes is unclear.1 Anderson et al conducted 3 analysis studies that found that topical corticosteroid use was associated with incident type 2 diabetes, and 2 of the studies demonstrated a dose-response relationship with higher potencies of topical corticosteroids.2 Consequently, the investigators made a strong recommendation to consider alternative treatments to high-potency topical corticosteroids that are potentially diabetogenic.

The studies had several strengths, including the replication of results across case-control and cohort designs with large, high-quality datasets and the inclusion of major confounders related to patient demographics, clinical comorbidities, and healthcare utilization.1 However, healthcare data do not capture actual medication use and exposure definitions do not fully reflect how topical corticosteroids are often used intermittently in practice. In addition, the association between topical corticosteroid use and incident type 2 diabetes may be less clear because itchiness and other inflammatory skin conditions are both associated with diabetes and topical corticosteroid prescribing, as noted in the appraisal.

The authors concluded that these findings suggest, there is a potential signal for an association with incident type 2 diabetes but should not be used to infer causality.1 They added that, potent topical corticosteroids should continue to be used sparingly, weighing the benefits and risks, and screening for type 2 diabetes should continue to be a routine part of chronic disease prevention and management.

Follow @EndoAdvisor

References

This article originally appeared on Dermatology Advisor

Please login or register first to view this content.

LoginRegister

Next post in Type 2 DiabetesClose

Read more:
Potent Topical Corticosteroids and Development of Type 2 Diabetes - Endocrinology Advisor

Diabetes mellitus, commonly known as diabetes, is a metabolic disease that causes high blood sugar. The hormone insulin moves sugar from the blood into your cells to be stored or used for energy. With diabetes, your body either doesnt make enough insulin or cant effectively use the insulin it does make.

Untreated high blood sugar from diabetes can damage your nerves, eyes, kidneys, and other organs.

There are a few different types of diabetes:

A rare condition called diabetes insipidus is not related to diabetes mellitus, although it has a similar name. Its a different condition in which your kidneys remove too much fluid from your body.

Each type of diabetes has unique symptoms, causes, and treatments. Learn more about how these types differ from one another.

Diabetes symptoms are caused by rising blood sugar.

The general symptoms of diabetes include:

In addition to the general symptoms of diabetes, men with diabetes may have a decreased sex drive, erectile dysfunction (ED), and poor muscle strength.

Women with diabetes can also have symptoms such as urinary tract infections, yeast infections, and dry, itchy skin.

Symptoms of type 1 diabetes can include:

It may also result in mood changes.

Symptoms of type 2 diabetes can include:

It may also cause recurring infections. This is because elevated glucose levels make it harder for the body to heal.

Most women with gestational diabetes dont have any symptoms. The condition is often detected during a routine blood sugar test or oral glucose tolerance test that is usually performed between the 24th and 28th weeks of gestation.

In rare cases, a woman with gestational diabetes will also experience increased thirst or urination.

Diabetes symptoms can be so mild that theyre hard to spot at first. Learn which signs should prompt a trip to the doctor.

Different causes are associated with each type of diabetes.

Doctors dont know exactly what causes type 1 diabetes. For some reason, the immune system mistakenly attacks and destroys insulin-producing beta cells in the pancreas.

Genes may play a role in some people. Its also possible that a virus sets off the immune system attack.

Type 2 diabetes stems from a combination of genetics and lifestyle factors. Being overweight or obese increases your risk too. Carrying extra weight, especially in your belly, makes your cells more resistant to the effects of insulin on your blood sugar.

This condition runs in families. Family members share genes that make them more likely to get type 2 diabetes and to be overweight.

Gestational diabetes is the result of hormonal changes during pregnancy. The placenta produces hormones that make a pregnant womans cells less sensitive to the effects of insulin. This can cause high blood sugar during pregnancy.

Women who are overweight when they get pregnant or who gain too much weight during their pregnancy are more likely to get gestational diabetes.

Both genes and environmental factors play a role in triggering diabetes. Get more information here on the causes of diabetes.

Certain factors increase your risk for diabetes.

Youre more likely to get type 1 diabetes if youre a child or teenager, you have a parent or sibling with the condition, or you carry certain genes that are linked to the disease.

Your risk for type 2 diabetes increases if you:

Your risk for gestational diabetes increases if you:

Your family, environment, and preexisting medical conditions can all affect your odds of developing diabetes. Find out which risks you can control and which ones you cant.

High blood sugar damages organs and tissues throughout your body. The higher your blood sugar is and the longer you live with it, the greater your risk for complications.

Complications associated with diabetes include:

Uncontrolled gestational diabetes can lead to problems that affect both the mother and baby. Complications affecting the baby can include:

The mother can develop complications such as high blood pressure (preeclampsia) or type 2 diabetes. She may also require cesarean delivery, commonly referred to as a C-section.

The mothers risk of gestational diabetes in future pregnancies also increases.

Diabetes can lead to serious medical complications, but you can manage the condition with medications and lifestyle changes. Avoid the most common diabetes complications with these helpful tips.

Doctors treat diabetes with a few different medications. Some of these drugs are taken by mouth, while others are available as injections.

Insulin is the main treatment for type 1 diabetes. It replaces the hormone your body isnt able to produce.

There are four types of insulin that are most commonly used. Theyre differentiated by how quickly they start to work, and how long their effects last:

Diet and exercise can help some people manage type 2 diabetes. If lifestyle changes arent enough to lower your blood sugar, youll need to take medication.

These drugs lower your blood sugar in a variety of ways:

You may need to take more than one of these drugs. Some people with type 2 diabetes also take insulin.

Youll need to monitor your blood sugar level several times a day during pregnancy. If its high, dietary changes and exercise may or may not be enough to bring it down.

According to the Mayo Clinic, about 10 to 20 percent of women with gestational diabetes will need insulin to lower their blood sugar. Insulin is safe for the growing baby.

The drug or combination of drugs that your doctor prescribes will depend on the type of diabetes you have and its cause. Check out this list of the various medications that are available to treat diabetes.

Healthy eating is a central part of managing diabetes. In some cases, changing your diet may be enough to control the disease.

Your blood sugar level rises or falls based on the types of foods you eat. Starchy or sugary foods make blood sugar levels rise rapidly. Protein and fat cause more gradual increases.

Your medical team may recommend that you limit the amount of carbohydrates you eat each day. Youll also need to balance your carb intake with your insulin doses.

Work with a dietitian who can help you design a diabetes meal plan. Getting the right balance of protein, fat, and carbs can help you control your blood sugar. Check out this guide to starting a type 1 diabetes diet.

Eating the right types of foods can both control your blood sugar and help you lose any excess weight.

Carb counting is an important part of eating for type 2 diabetes. A dietitian can help you figure out how many grams of carbohydrates to eat at each meal.

In order to keep your blood sugar levels steady, try to eat small meals throughout the day. Emphasize healthy foods such as:

Certain other foods can undermine efforts to keep your blood sugar in control.Discover the foods you should avoid if you have diabetes.

Eating a well-balanced diet is important for both you and your baby during these nine months. Making the right food choices can also help you avoid diabetes medications.

Watch your portion sizes, and limit sugary or salty foods. Although you need some sugar to feed your growing baby, you should avoid eating too much.

Consider making an eating plan with the help of a dietitian or nutritionist. Theyll ensure that your diet has the right mix of macronutrients. Go here for other do's and don'ts for healthy eating with gestational diabetes.

Anyone who has symptoms of diabetes or is at risk for the disease should be tested. Women are routinely tested for gestational diabetes during their second or third trimesters of pregnancy.

Doctors use these blood tests to diagnose prediabetes and diabetes:

To diagnose gestational diabetes, your doctor will test your blood sugar levels between the 24th and 28th weeks of your pregnancy.

The earlier you get diagnosed with diabetes, the sooner you can start treatment. Find out whether you should get tested, and get more information on tests your doctor might perform.

Type 1 diabetes isnt preventable because its caused by a problem with the immune system. Some causes of type 2 diabetes, such as your genes or age, arent under your control either.

Yet many other diabetes risk factors are controllable. Most diabetes prevention strategies involve making simple adjustments to your diet and fitness routine.

If youve been diagnosed with prediabetes, here are a few things you can do to delay or prevent type 2 diabetes:

These arent the only ways to prevent diabetes. Discover more strategies that may help you avoid this chronic disease.

Women whove never had diabetes can suddenly develop gestational diabetes in pregnancy. Hormones produced by the placenta can make your body more resistant to the effects of insulin.

Some women who had diabetes before they conceived carry it with them into pregnancy. This is called pre-gestational diabetes.

Gestational diabetes should go away after you deliver, but it does significantly increase your risk for getting diabetes later.

About half of women with gestational diabetes will develop type 2 diabetes within 5 to 10 years of delivery, according to the International Diabetes Federation (IDF).

Having diabetes during your pregnancy can also lead to complications for your newborn, such as jaundice or breathing problems.

If youre diagnosed with pre-gestational or gestational diabetes, youll need special monitoring to prevent complications. Find out more about the effect of diabetes on pregnancy.

Children can get both type 1 and type 2 diabetes. Controlling blood sugar is especially important in young people, because the disease can damage important organs such as the heart and kidneys.

The autoimmune form of diabetes often starts in childhood. One of the main symptoms is increased urination. Kids with type 1 diabetes may start wetting the bed after theyve been toilet trained.

Extreme thirst, fatigue, and hunger are also signs of the condition. Its important that children with type 1 diabetes get treated right away. The disease can cause high blood sugar and dehydration, which can be medical emergencies.

Type 1 diabetes used to be called juvenile diabetes because type 2 was so rare in children. Now that more children are overweight or obese, type 2 diabetes is becoming more common in this age group.

About 40 percent of children with type 2 diabetes dont have symptoms, according to the Mayo Clinic. The disease is often diagnosed during a physical exam.

Untreated type 2 diabetes can cause lifelong complications, including heart disease, kidney disease, and blindness. Healthy eating and exercise can help your child manage their blood sugar and prevent these problems.

Type 2 diabetes is more prevalent than ever in young people. Learn how to spot the signs so you can report them to your childs doctor.

Some types of diabetes like type 1 are caused by factors that are out of your control. Others like type 2 can be prevented with better food choices, increased activity, and weight loss.

Discuss potential diabetes risks with your doctor. If youre at risk, have your blood sugar tested and follow your doctors advice for managing your blood sugar.

Visit link:
Diabetes: Symptoms, Causes, Treatment, Prevention, and More

Heres a look into the next generation of low-calorie sugar alternatives and continuous glucose ... [+] monitoring systems set to change the outlook for health in the U.S. and worldwide.

By 2030, almost 400,000 Americans a year will die of diabetes - many of them unnecessarily. Synthetic biology companies are working hard to ensure thats not the case. Heres a look into the next generation of continuous glucose monitoring systems and low-calorie sugar alternatives set to change the outlook for health in the U.S. and worldwide.

Diabetes is a health crisis on the rise with no signs of slowing down any time soon. By 2030, 54.9 million Americans are predicted to have either Type 1 or Type 2 diabetes, which could mean almost 400,000 deaths annually. Many of these deaths are entirely preventable, with lifestyle factors such as body weight being a huge contributing factor in developing Type 2 diabetes.

Sugar is a major villain in the story. The high calorie, high kick sweetness that pervades our fast food and fizzy beverageseven sneaking into products that youd never expect. Thought that granola for breakfast was a healthy option? Think again. It can be laden with sugar, up to 18 grams (thats more than five teaspoons) per half-cup serving.

Surprise: A single tablespoon of ketchup has almost 4 grams of sugar.

We dont know for sure all the mechanisms behind how we develop Type 2 diabetes, but we do know that the global prevalence has doubled since 1980 - and lifestyle is largely to blame. Thats where biohackers and synthetic biology companies are stepping in.

Biohacking also known as DIY biology is a broad term that refers to people doing science outside of the usual academic and industrial settings. It can cover anything from exploring biological engineering through glowing yeast cells to experimenting on ones own body with the hope of boosting physical and cognitive performance (the latter of which I do not recommend).

Always forward thinking, biohackers are taking things into their own hands, attempting to head off disaster before it arrives at their front doors. A favorite tool is continuous glucose monitoring (CGM), a much preferable alternative to finger pricking thats normally used by those with diabetes. Unlike finger pricking, it also provides continuous read-outs of blood glucose levels rather than single point-in-time readings, providing people a better understanding of how their body responds to food, exercise, or stress, and enabling them to catch dangerous drops in blood sugar before they happen.

Biohacker Ella Mihov wrote on her Medium blog that most people in developed countries would benefit from the occasional insights of CGM, to see how your average diet and lifestyle is impacting your metabolism, and as a way to thwart progression toward chronic metabolic disease like obesity and diabetes.

Mihov is far from alone in this pursuit. The internet is teeming with examples rich in information for anyone wanting to hack and track their blood glucose levels. In combination with innovations such as Eran Segals groundbreaking microbiome-based method, which uses metrics on an individuals gut microbiota, blood glucose levels, and other physiological parameters to give users diet plans that avoid sugar spikes, such information really could help reduce the huge numbers of people who present with Type 2 diabetes in the long run.

Yet, even with enthusiastic adoption, the reality for Type 2 diabetics is that current CGM solutions cause pain and discomfort after repeated use, as well as posing an infection risk, according to a recent review of the current options.

In fact, the authors suggest that a genuinely non-invasive device for glucose measurement would represent a life-changing factor for millions of patients around the world. Due to a lack of sensitivity of truly non-invasive options, the field is open to many possibilities.

Enter Carbometrics, a specialist chemistry company set up after the Bristol-based team sold university spin-out Ziylo in a deal that could be worth hundreds of millions of pounds, which is at the forefront of an incredibly disruptive new blood glucose-sensing solution: a tiny, glucose-sensing molecule that will minimize the size of an implant while providing accurate monitoring.

As Andy Chapman, CEO of Carbometrics, tells me, weve developed a synthetic molecule that binds glucose with unprecedented selectivity. With some clever design work, we can build versions of this molecule to determine blood glucose concentration. Were really keen to get it out there as a minimally invasive, longer lasting and cheaper solution for blood glucose sensing.

The realization of this technology would represent a breakthrough in developing that next generation of CGM the world is crying out for. The current options work for a matter of days, perhaps weeks. Carbometrics propose something much longer-lasting, which could perhaps self-dissolve like stitches - exciting news for diabetics and biohackers alike.

The company is also excited about taking on what is labelled the holy grail when it comes to diabetes: glucose-responsive insulin. This cutting edge idea in insulin therapy hopes to reduce the very real risk of hypoglycemia, improve overall blood glucose control, and require fewer injections.

Were trying to use our molecule to make a dimmer switch for insulin that is controlled by blood glucose level, says Chapman. The net result would be a substantial buffering of insulins potency, which would allow the patient to achieve better blood glucose control with a reduced risk of hypoglycemia. Its a massively complicated task, but we have the machinery and the concept.

Interestingly, as far as we know, sugar itself doesnt appear to directly cause Type 2 diabetes. But a diet high in added sugar does appear to increase your risk of developing the disease, as a number of studies indicate that have looked at the effect of sugary soda beverages.

So what about cutting out sugar from your diet and replacing it with alternatives? Youd better hope theyre the right alternatives.

Artificial sweeteners have been associated with the very same negative effects of sugar: obesity, diabetes, high blood pressure, and heart disease. Research suggests that this could be due to changes in the gut microbiotathe microorganisms that live in your gastrointestinal tract, digesting fiber, producing vitamins, and warding off pathogens.

Stevia is a naturally sweet substitute for sugar, but can synthetic biology make it less bitter?

Stevia is a natural alternative, which research in mice suggests could even help prevent Type 2 diabetes in the first place, through action on a protein that is important both in taste perception and in releasing insulin after a meal.

Stevia is super sweet but unfortunately has a bitter aftertaste. Some synthetic biology companies are tackling this problem. Conagen, who after breaking stevia down into its different components are finding solutions that are much sweeter, such as their commercial product BESTEVIA. Amyris late last year launched a similar product, PURECANE, which CEO John Melo says brings the sweet out of sugarcane without the calories. And the protein and enzyme experts at Codexis have partnered with Tate & Lyle to use a breakthrough enzyme cascade system to achieve better-tasting stevia in TASTEVA M Stevia Sweetener.

The collaboration to develop jointly the breakthrough TASTEVA M process is the second successful food and beverage ingredient process innovation partnership between Tate & Lyle and Codexis, said John Nicols, Codexis President and Chief Executive Officer. Each of those projects rapidly progressed from concept to commercializable process and, in fact, partnering on the TASTEVA M process was initiated just over two years ago (link). We expect over time that our enzymes for TASTEVA M will become among our leading revenue-producing products in our Performance Enzyme portfolio.

Where Conagen, Codexis, and Amyris are improving Stevia, other companies are exploring yet more options. ARCITEKBio is a UK-based spin out of Aberystwyth University producing Xylitolanother natural sweetener with a $1.4 billion marketthrough converting agricultural waste such as wheat straw and wood pulp in an entirely renewable process.

Where even natural sweeteners struggle, however, is maintaining the structural integrity of solid foods such as cakes and pastries, which are another major source of high dietary sugar intake. STEM! Sugar, therefore, is working on ways to tackle that particular problem by developing alternatives to sugar that provide the functionality without the calories.

The sugar problem is not necessarily a problem of excess sugar but using the wrong type of sugars. Our ingredients are indeed sugars, but theyre a different type of sugars to those you squeeze out of a cane or beet plant. Our sugars are fiber-derived sugars, CEO Tom Simmons explains. They behave like sugars in food but work in the body like fiber - so without the negative health effects typically associated with sugar.

Even cakes, quite soon, might be an entirely guilt-free pleasure.

Whether youre a health conscious biohacker trying to prevent Type 2 diabetes or a patient living with the realities of having to monitor and control your blood sugar levels, these synthetic biology solutions point towards a much better prognosis.

With an increased acceptance of the deliciously sweet, zero-calorie alternatives already pervading the market, it will be interesting to see whether those predictions of 54.9 million Americans presenting with diabetes in ten years time will be diminished as we enter into a healthier, sugar-free future.

Follow me on twitter at @johncumbers and @synbiobeta. Subscribe to my weekly newsletters in synthetic biology and space settlement.

Thank you to Peter Bickerton for additional research and reporting in this article. Im the founder of SynBioBeta, and some of the companies that I write aboutincluding Conagen and Codexisare sponsors of the SynBioBeta conference and weekly digest heres the full list of SynBioBeta sponsors. Im also a partner at DCVC, which has invested in STEM!

Follow this link:
Meet The Companies Waging War On Sugar And Diabetes - With Synthetic Biology - Forbes

Individuals who want to learn how to better manage diabetes are invited to participate in a course offered by Penn State Extension on March 26 from 12:30 to 3 p.m. and April 2, 9, and 16 from 12:30 to 2:30 p.m.

There will be a follow-up class on June 25.

The workshops are held at the YMCA of Indiana County, 60 N. Ben Franklin Road.

Dining with Diabetes is a nationally accredited diabetes education program that is geared toward anyone who has type 2 diabetes or pre-diabetes, has a family member with type 2 diabetes or is at risk for developing diabetes. Trained extension educators, in consultation with registered dietitians and diabetes educators, lead the discussions.

Each class offers information on healthy food and physical activity choices, food demonstrations and tasting, and guidance on important numbers to know for managing diabetes.

In addition to program-related booklets, participants will receive the Dining with Diabetes cookbook and have the option of having their A1C tested at the first and follow-up classes.

A1C is a nonfasting blood test obtained by a finger stick. Results show a three-month average blood glucose level.

Continued here:
Dining with diabetes class to be offered | News - Indiana Gazette

Each month, local health care professionals answer your questions. This month, Katie Rhew, a family nurse practitioner at Mercy Health Physician Partners North Ottawa Family Medicine, answers your questions about diabetes.

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

kAmkDEC@?8m#96Hik^DEC@?8m s:236E6D 😀 2 5:D62D6 E92E :?9:3:ED E96 3@5JD 23:=:EJ E@ 5:86DE DF82C] %96C6 2C6 EH@ EJA6D @7 5:236E6D] %JA6 x 5:236E6D 😀 H96? J@FC 3@5J D:>A=J 5@6D ?@E AC@5F46 :?DF=:?[ H9:49 😀 E96 496>:42= E92E 96=AD FD 5:86DE E96 DF82C E92E H6 62E 2?5 5C:?<] xE :D FDF2==J 5:D4@G6C65 62C=J :? =:76 W367@C6 286 adX] %JA6 xx 5:236E6D :D >F49 >@C6 4@>>@?] !6@A=6 H:E9 %JA6 xx 5:236E6D 92G6 3F:=E FA 2 C6D:DE2?46 E@ :?DF=:?[ 2?5 E96:C 3@5:6D 42? ?@ =@?86C AC@46DD DF82C AC@A6C=J]k^Am

kAmkDEC@?8m"i (92E 42FD6D 5:236E6Dnk^DEC@?8mk^Am

kAmkDEC@?8m#96Hik^DEC@?8m %JA6 xx 5:236E6D EJA:42==J C6DF=ED 7C@> 2 5:6E 9:89 😕 42C3@9J5C2E6D 2?5 =@H 😕 7CF:ED[ G686E23=6D 2?5 H9@=6 8C2:?D] %9:D[ 4@>3:?65 H:E9 2 =24< @7 6I6C4:D6[ 42? =625 E@ 5:236E6D]k^Am

kAmkDEC@?8m"i (92E 2C6 E96 DJ>AE@>Dnk^DEC@?8mk^Am

kAmkDEC@?8m#96Hik^DEC@?8m %96 >@DE 4@>>@? H2C?:?8 D:8?D 😕 25F=ED 2C6 :?4C62D65 E9:CDE[ FC:?2E:@? 2?5 9F?86C] }F>3?6DD 😕 E96 7:?86CE:AD[ @C 492?86D 😕 6J6D:89E[ 2C6 2=D@ H2C?:?8 D:8?D] r9:=5C6? 42? 2=D@ 56G6=@A 5:236E6Dj E96:C DJ>AE@>D @7E6? :?4=F56 72E:8F6 2?5 F?:?E6?565 H6:89E =@DD]k^Am

kAmkDEC@?8m"i w@H 😀 5:236E6D 5:28?@D65nk^DEC@?8mk^Am

kAmkDEC@?8m#96Hik^DEC@?8m #@FE:?6 3=@@5 H@C< FDF2==J :?4=F56D 2 E6DE 7@C 8=F4@D6] x7 E92E C6DF=E :?5:42E6D E92E J@F 2C6 AC65:236E:4[ J@FC 5@4E@C H:== AC@323=J 5:D4FDD =:76DEJ=6 >@5:7:42E:@?D H:E9 J@F] x7 E96 C6DF=E 😀 9:89 6?@F89[ J@FC 5@4E@C >2J AC6D4C:36 @E96C E6DED E@ 56E6C>:?6 J@FC DE2EFD 2?5 H92E E@ 5@ ?6IE]k^Am

kAmkDEC@?8m"i w@H 5@ J@F EC62E 5:236E6Dnk^DEC@?8mk^Am

kAmkDEC@?8m#96Hik^DEC@?8m s:236E6D 😀 2 AC@8C6DD:G6 5:D62D6] x7 J@F 2C6 23=6 E@ 56E64E :E 62C=J[ E96? =:76DEJ=6 >@5:7:42E:@?D 42? 36 G6CJ 67764E:G6] $:>A=6 DE6AD[ =:<6 :?4C62D:?8 J@FC :?E2<6 @7 H2E6C 2?5 564C62D:?8 J@FC :?E2<6 @7 DF82CJ 5C:?A24E] %96 7@@5 J@F 62E 😀 AC@323=J E96 >@DE :>A@CE2?E 7@C> @7 EC62E>6?E] x 2=H2JD C64@>>6?5 E92E A2E:6?ED 7@==@H E96 w62=E9J t2E:?8 !=2E6 C64@>>6?52E:@?D 56G6=@A65 3J w2CG2C5 |65:42= $49@@= 2?5 w2CG2C5 $49@@= @7 !F3=:4 w62=E9] %9:D 4@>3:?2E:@? @7 H9@=6 8C2:?D[ 962=E9J AC@E6:?D[ 7CF:ED 2?5 G686E23=6D H:== 96=A 8F:56 A2E:6?ED E@H2C5 7@@5D E92E 92G6 =@H6C @G6C2== DF82C 2?5 C6BF:C6 2 =@?86C 5:86DE:@? AC@46DD WE96C67@C6 D=@H:?8 E96 C6=62D6 @7 :?DF=:? :?E@ E96 3=@@5DEC62>X] ~?46 5:236E6D 92D AC@8C6DD65 E@ E96 A@:?E E92E =:76DEJ=6 >@5:7:42E:@?D 2C6 ?@E 6?@F89[ E96 EC62E>6?E 364@>6D >@C6 :?E6?D6] ~C2= @C A6C92AD :?;64E65 :?DF=:? 42? 36 C6BF:C65 E@ <66A E96 3@5JD DF82C =6G6=D :? 4964<]k^Am

kAmk6>m%96 :?7@C>2E:@? 4@?E2:?65 😕 E9:D 2CE:4=6 😀 7@C :?7@C>2E:@?2= 2?5 65F42E:@?2= AFCA@D6D @?=J] xED AFCA@D6 😀 E@ AC@>@E6 3C@25 4@?DF>6C F?56CDE2?5:?8 @7 G2C:@FD 962=E9 E@A:4D 2?5 😀 ?@E :?E6?565 E@ 36 2 DF3DE:EFE6 7@C 25G:46 7C@> J@FC A6CD@?2= A9JD:4:2?]k^6>mk^Am

kAmk6>m(6 H@F=5 =:<6 E@ 962C H92E E@A:4D 2C6 @7 :?E6C6DE E@ J@F] !=62D6 6>2:= 2Dmk^Am

kAmk6>mp? :?5:G:5F2= ?665:?8 :>>65:2E6 >65:42= 96=A D9@F=5 42== h``[ @C 5C:G6 E@ E96 ?62C6DE 6>6C86?4J C@@> @C FC86?E 42C6 46?E6C] $F3>:DD:@? @7 2 BF6DE:@? 3J :ED6=7 5@6D ?@E 4C62E6 2 5@4E@C^A2E:6?E C6=2E:@?D9:A] !=62D6 36 25G:D65 E92E DF3>:DD:@? @7 >65:42= BF6DE:@?D E@ E96 6>2:= D:E6 😀 ?@E D64FC6 2?5 4@?7:56?E:2= @C D6?D:E:G6 :?7@C>2E:@? D9@F=5 ?@E 36 7@CH2C565]k^6>mk^Am

View post:
What is diabetes? | Health Care - Grand Haven Tribune

HARTFORD Im into Hot Wheels, coin collecting and advocating, says Logan Merwin, noting that advocating might be an unusual hobby for a 13-year-old but it comes naturally to him. I figured out that Im actually not half bad at public speaking.

The teen recently spoke out at a public hearing at the Legislative Office Building to enact change. A proposed bill aims to make diabetes treatment and care more affordable. Our interview occurred after what Logan calls a bad night.

My blood sugar was like a roller coaster, he says. Every hour we were waking up to a different alarm, needing to treat it.

Diabetes is a very time-consuming disease for the parents and for the kid, adds Logans mom, Samantha who says her sons type 1 diabetes diagnosis at 17 months old was life-changing. Most years, the family has spent between $5,000 and $9,000 dollars, out of pocket, on necessary equipment and medication.

He has no choice but to take insulin, she says. Without insulin, he dies. Insulin is like our water..we dont save for college. We save for his medical expenses when hes going to be in his twenties.

But, they believe this move to put price caps in insulin and supplies will make a huge difference. Through the legislative process, the teenager has learned a valuable lesson.

Kids have a voice, we can change things if we want to, dont ever underestimate us, Logan says. In fact, hes always achieving running races to raise money for the cause, looking to change the landscape for himself and others.

He feels like diabetes pushes him further in life and Im confident that thats true, says Samantha.

I never let it stop me, adds Logan.

The bill has a lot of bipartisan support and the Merwins are hopeful it will get passed before the end of the legislative session.

Go here to read the rest:
Haddam boy with type 1 diabetes is passionate advocate for price caps on insulin and supplies - WTNH.com

Tandem Diabetes Care (NASDAQ:TNDM) owned less than 5% of the insulin pump market in the U.S. five years ago. The market has grown 40% since then, but the company now has 20% market share. It's not an overnight success, but it's close.

Wall Street hasn't hesitated to reward the company's progress. Revenue increased 237% from 2017 to 2019, which has propelled the growth stock 3,000% in that three-year span. Tandem Diabetes Care now trades a market cap of $4.5 billion.

While the business delivered its best year ever in 2019 and healthy revenue growth is expected in 2020, investors might need to prepare for volatility as Wall Street shifts its focus to the bottom line.

Image source: Getty Images.

Tandem Diabetes Care develops insulin pumps for individuals with type 1 diabetes and type 2 diabetes, although the former comprises 90% of customers.

The company's flagship product is the t:slim X2 insulin pump, which launched in late 2016 and has amassed market share since. Technically, the complete product offering is a regulator-approved combination of hardware and software. Patients appreciate the ease of use provided by a large touchscreen, Bluetooth compatibility, the relatively small size and low weight of the pump, and the ability to receive over-the-air updates. Meanwhile, Tandem Diabetes Care has developed two algorithms, Basal-IQ and Control-IQ, to make the devices even easier to use.

A focus on being user-friendly has also been very shareholder-friendly. Tandem Diabetes turned in its best year of operations ever in 2019, as the growth rate accelerated from previous years.

Metric

2019

2018

Change (YoY)

Revenue

$362.3 million

$183.9 million

97%

Gross profit

$194.2 million

$89.8 million

116%

Operating expenses

$210.9 million

$134.4 million

57%

Operating income

($16.7 million)

($44.6 million)

N/A

Data source: Press release. YoY = year over year.

While the company expects to continue investing in scaling up its technology platform in 2020, management also expects the rate of revenue growth to slow. Tandem Diabetes Care issued the following full-year 2020 guidance:

Metric

Full-Year 2020, Expected

Full-Year 2019, Actual

Change (YoY)

Revenue

$450 million to $465 million

$362 million

24% to 28%

Gross margin

54%

54%

No change

Adjusted EBITDA as % of revenue

12% to 14%

13%

No change at midpoint

Data source: Press release. YoY = year over year.

Achieving year-over-year revenue growth of 24% may not look as impressive as nearly doubling last year, but it's still pretty impressive considering the scale of t:slim X2 sales. It's also worth pointing out that Tandem Diabetes Care has routinely underestimated growth with guidance in past quarters.

Nonetheless, shareholders could experience volatility if progress doesn't match up with Wall Street expectations. Analysts expect revenue of about $459 million and earnings per share (EPS) of $0.02 in 2020, according to numbers compiled by Yahoo. That level of revenue is closer to the top end of the company's range, but not unreasonable. The issue might come down to earnings.

Tandem Diabetes Care posted a loss of $0.42 per share in 2019. How much can it improve the bottom line while investing in the future? Based on initial guidance, the company expects to deliver gross profit of $243 million to $251 million in 2020. That means operating expenses would have to grow by about 10% to 15% from 2019 for the business to have a shot at meeting Wall Street expectations for EPS. That expectation might be incompatible with investments in growth. That might explain why shares dipped when full-year 2019 earnings and full-year 2020 guidance were first reported.

Considering shares of Tandem Diabetes Care trade at about 10 times expected 2020 sales and 23 times book value, the tussle between management's expectations and those of Wall Street could force analysts to be a little more critical of the stock's premium valuation. That's not something investors with a long-term mindset should be too concerned about, but shareholders should be prepared for the stock to encounter its first real volatility in several years.

Originally posted here:
Will Tandem Diabetes Care Keep Its Premium Valuation in 2020? - The Motley Fool

The global advanced wound care management market is prognosticated to push its growth as chronic diseases show high prevalence in different parts of the world. Demand for advanced wound care management could gain support from the need to care for wounds before they grow into serious infections or other medical complications.

Transparency Market Research (TMR) envisions the global advanced wound care management market to grow at a 6.3% CAGR for the forecast tenure 2017-2024. By the end of 2024, the market could be valued at an US$11.1 bn. Currently, it stands at a US$7.2 bn valuation. Introduction of new products in the market could translate into strong growth opportunities in the coming years. In July 2018, RedDress innovative wound care product, RD1 received the green signal from the FDA in the form of 510(k) clearance.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16139

Speedy Recovery Helps Active Wound Care to Exhibit High Market Growth Rate

Players operating in the global advanced wound care management market may face the challenge posed by bottlenecks created because of limited reimbursement scenarios and extortionate cost of products. However, rising awareness about the significance and advantages of early wound treatment is anticipated to up the demand in the market.

Buy Advanced Wound Care Management Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=16139&ltype=S

Advanced wound care management could find increased application in diabetic foot ulcer treatment due to improved availability of therapeutics and increasing prevalence of the disease. However, chronic wound treatment may still remain as a leading application considering increasing incidence of chronic wounds.

Regionally, North America is foreseen to generate a leading amount of revenue for the global advanced wound care management market. By the end of the final forecast year, the regional market could be worth a US$4.4 bn. Supporting the growth of the region in the market could be factors such as early adoption of new technologies. On the other hand, new investment opportunities could make Asia Pacific an attractive market.

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough, Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=16139

Key players operating in the global advanced wound care management market include Smith & Nephew plc, Acelity L.P., Inc., Mlnlycke Health Care AB, ConvaTec Inc., B. Braun Melsungen AG, Coloplast A/S, 3M Healthcare, Integra LifeSciences Corporation, Cardinal Health, PAUL HARTMANN AG, BSN Medical, Hollister Incorporated, Organogenesis Inc., and Medline Industries, Inc.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

ContactTransparency Market ResearchState Tower,90 State Street,Suite 700,Albany NY - 12207United StatesUSA - Canada Toll Free: 866-552-3453Email: sales@transparencymarketresearch.comWebsite: https://www.transparencymarketresearch.com/

Read more from the original source:
Advanced Wound Care Management Raises Strong Demand with Rising Incidence of Diabetes and Other Chronic Diseases, TMR - BioSpace

Older people who experience excessive sleepiness in the daytime could be at a greater risk of developing type 2 diabetes, according to new research that will be presented at the American Academy of Neurologys 72nd Annual Meeting in Toronto at the end of April.

Feeling overly tired, despite getting adequate sleep at night, is called hypersomnolence and it has previously been linked to cancer and high blood pressure.

Study author Dr Maurice Ohayon, from Stanford University in California, said: Paying attention to sleepiness in older adults could help doctors predict and prevent future medical conditions.

More than 10,000 people were recruited for the research, which involved the participants being interviewed twice over the phone, three years apart.

Of all the people, 34% were aged 65 or older. During the first phone interview, 23% of people over 65 fit the criteria of excessive sleepiness. Through the study, their risk of developing type 2 diabetes or blood pressure was found to be 2.3 times higher than the less sleepy participants. They were also twice as likely to develop cancer.

Researchers identified 840 people who said they had experienced sleepiness in the day at the first phone interview. Of that, 6.2% who reported sleepiness during this first interview developed type 2 diabetes, compared to just 2.9% of those who were never sleepy during the day.

Those who reported excessive sleepiness only in the second interview were 50% more likely to develop diseases in the musculoskeletal system like arthritis.

A member of the American Academy of Neurology, Dr Ohayon said: Older adults and their family members may want to take a closer look at sleeping habits to understand the potential risk for developing a more serious medical condition.

The study findings were unveiled at the American Academy of Neurologys 72nd Annual Meeting in Canada.

Original post:
Excessive sleepiness linked to higher health risks in older people - Diabetes.co.uk

Diabetics, you can add these drinks to your diet

Diabetes is a long term condition that requires constant management of blood sugar levels. Your diet plays an important role when it comes to maintaining healthy blood sugar levels. Before planning your diet, diabetics should check the effect of the food consumed on your blood sugar levels. Most drinks are loaded with added sugar which can create fluctuations on your blood sugar levels. Even packed juices are loaded with sugar with very few nutrients. If you are consuming fresh fruit juice, you need fruits in large quantities to prepare a small amount of juice. This can also contribute to the consumption of too much sugar. Similarly, maximum drinks are loaded with sugar. There are very few options safe for diabetics. Here are a few drinks diabetics can add to their diet.

Vegetables are loaded with essential nutrients. One should consume enough vegetables throughout the day. There are a variety of vegetables to choose from. You can combine your favourite vegetables to prepare fresh and nutrient-dense juice. Green leafy vegetables are the best ones to choose from.

Diabetes: Vegetable juices are loaded with health benefitsPhoto Credit: iStock

Also read:Can Diabetics Eat Fruits? Know Tips To Choose The Right Fruits

Good new diabetics! You can drink coffee. According to studies drinking coffee can reduce the risk of developing diabetes. If you want to add coffee to your diabetes diet, do not add cream to it. Also, choose the amount of sugar wisely.

Also read:Diagnosed With Diabetes? Here's How You Can Maintain Healthy Blood Sugar Levels

Teas are loaded with health benefits. Consuming tea loaded with or milk is not a healthy choice for diabetics. Instead, you can choose herbal teas which are also loaded with several health benefits. There are several herbal teas to choose from. Some of these can also help you control blood sugar levels. Take recommendations from your doctor to choose the right tea.

Herbal teas can provide you several health benefitsPhoto Credit: iStock

Dairy products also play an important role in your diet. These products are loaded with several health benefits. Diabetics can add milk to their diet but choose unsweetened and low-fat milk. You can once check with your doctor about the portion size according to your blood sugar levels.

Also read:Diabetes: These Leaves Can Lower Your Blood Sugar Levels Effectively; Learn How To Use Them

Disclaimer: This content including advice provides generic information only. It is in no way a substitute for qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information.

The rest is here:
Diabetes Diet: These Are The Best Drinks Other Than Water For People With Diabetes - NDTV News

Ewelina Bk,1 Ewa Marcisz-Dyla,2 Agnieszka Mynarska,3 Danuta Sternal,1 Monika Kadubowska,1 Czesaw Marcisz3

1Faculty of Health Sciences, University of Bielsko-Biala, Bielsko-Biala, Poland; 2Department of Anxiety Disorders, Hospital of Ministry of Internal Affairs, Katowice, Poland; 3Department of Gerontology and Geriatric Nursing, School of Health Sciences, Medical University of Silesia, Katowice, Poland

Correspondence: Ewelina BkFaculty of Health Sciences, University of Bielsko-Biala, ul. Willowa 2, Bielsko-Biala 43-309, PolandTel +48 33 827 9198Email ewelina.bak76@wp.pl

Purpose: Patients with diabetes are at increased risk of developing depression. The aim of the study was to determine the occurrence of depressive symptoms in patients with type 1 (T1DM) and type 2 diabetes (T2DM), including the association with different independent sociodemographic and clinical variables.Patients and Methods: The studies were carried out on 618 people, including 115 patients with T1DM and 215 patients with T2DM and 288 people without diabetes constituting two control groups. Subjects were characterized in terms of sociodemographic, clinical and biochemical aspects, and the occurrence of depressive symptoms using Beck Depression Inventory (BDI) was determined. In the logistic regression analysis, the correlations between BDI score and with independent variables such as sex, age, body mass index, duration of diabetes, HbA1c level, diabetic complications and mean arterial pressure were examined.Results: The mean BDI score was significantly higher in women and men with T1DM and T2DM compared to controls. In diabetic patients, depressive symptoms occurred more often in women than in men. Among patients with T1DM, the incidence of depressive symptoms was 17.5% of the women and 8.6% of the men and in patients with T2DM, the incidence ofdepressive symptoms was revealed in 28.9% of the women and in 19.8% of the men. In patients with T1DM and T2DM, the occurrence of depressive symptoms increases with age, HbA1c level and complications, and the risk of depressive symptoms turned out to be almost three times higher in women than in men with T2DM.Conclusion: The prevalence of depressive symptoms in diabetic patients is higher than in non-diabetics. Depressive symptoms account for 13% of the patients with T1DM and 24.7% of the patients with T2DM. The risk of depressive symptoms in T1DM and T2DM increases with age, HbA1c level and the presence of complications, and it is gender-related in T2DM only.

Keywords: type 1 diabetes, type 2 diabetes, depressive symptoms, Beck Depression Inventory

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

See more here:
Prevalence of Depressive Symptoms in Patients with Type 1 and 2 Diabet | PPA - Dove Medical Press

Diabetic foot ulcers continue to be a major cause of morbidity and mortality in patients with diabetes despite several standard of care options. A paper published in the American Journal of Clinical Dermatology highlights new trends in the management of diabetic foot ulcers, including the use of adjunctive therapies.

Pressure relief, debridement, infection management, and revascularization comprise the current gold standard of care for diabetic foot ulcers. Despite the potential benefit of each component, this regimen alone may not be sufficient for the prevention and management of foot ulcers in patients with diabetes. Although prevention is key, new trends in diabetes foot ulcer management have been shown to greatly improve treatment beyond current standard of care.

For ulcers that persist beyond the 4-week standard of care treatment recommendation, adjunctive approaches may be an option. Negative pressure wound therapy, for instance, may potentially assist in promoting wound healing via the application of intermittent or continuous negative pressure to a wound. Hyperbaric oxygen therapy is another adjunctive approach that has been suggested for diabetic foot ulcers; however, the efficacy of this strategy is considered controversial, according to the published literature.

There is an increasing trend toward the use of bioengineered skin substitutes as adjunct therapy for treating and closing diabetic foot ulcer wounds. Skin substitutes used for diabetic foot ulcers include dermal substitutes consisting of either acellular or cellular extracellular matrix and composite substitutes of dermal and epidermal components. In addition, a growing trend has been observed in the use of topical growth factors for diabetic foot ulcers.

There is currently only 1 topical recombinant human platelet-derived growth factor approved by the US Food and Drug Administration for the treatment of foot ulcers in patients with diabetes. The product may be more cost effective compared with standard of care alone. Although promising, high doses of this adjunctive approach have been linked to an increased risk for cancer.

Electrical stimulation is another emerging technologic approach for treatment of hard to treat foot ulcer wounds. Evidence to support this strategy is mostly found in individual case reports and small studies. The newest trend in diabetic foot ulcer adjunctive therapy pressure and temperature feedback devices is increasingly used in foot ulcer prevention strategies in patients with diabetic peripheral neuropathy.

Although many of the emerging approaches are novel and most lack sufficient evidence to support their clinical efficacy, the investigators wrote that the new standard of care for the management of diabetic foot ulcers should integrate a multimodal approach that addresses the many factors that contribute to ulcer development as well as those that promote wound healing.

Follow @DermAdvisor

Reference

Aldana PC, Khachemoune A. Diabetic foot ulcers: appraising standard of care and reviewing new trends in management [published online December 17, 2019]. Am J Clin Dermatol. doi:10.1007/s40257-019-00495-x

Original post:
Prevention and Treatment of Diabetic Foot Ulcers May Benefit From Multimodal Approach - Dermatology Advisor

A lengthy record is directed at diabetics in other words. in order to prevent diabetes customers. This is simply because the sugar amount in diabetes begins to be high, it is therefore better to keep away from such foods that have even more volume.

Should not consume this thing:

# Beans: Beans may possibly not be nice but they are saturated in starch.

->In this situation, and even though this green veggie is here, it must be averted as a result of extra starch. If you prefer beans, you can easily boil it and eat it.

# Potato or sweet-potato: Potato and sankarakandi are packed with starch and sweetness. Diabetes customers should prevent consuming this too. Boiled may be consumed sometimes.

# Pumpkin: Pumpkin can be really nice. Green pumpkin is consumed sometimes. By steering clear of these veggies, you are able to help keep your self far from dangerous conditions brought on by diabetes.

# Beetroot: It contains much more sweetness. It isnt that you simply cant consume beet after all, but its volume can be extremely tiny or as soon as in per week.

Link:
Diabetes customers should not eat this thing - Sahiwal Tv

eKares inSight 3D wound management platform

FAIRFAX, Va. (PRWEB) March 03, 2020

eKare has been selected after an open competition to join the prestigious Diabetic Foot Consortium (DFC) organized by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a branch of the National Institute of Health (NIH). The objective of the DFC is to establish an organizational framework at the national level to facilitate integrated clinical and translational research to improve outcomes for patients with diabetic foot ulcers (DFUs).

DFUs represent a significant quality of life issue for patients and cost about $13 billion nationally.(1) The DFC is prioritizing DFU research and accelerating the development and validation of wound biomarkers to improve prediction of outcomes. The consortium includes:

eKares inSight, a comprehensive 3D wound management system, will be uniformly utilized across the institutions for standardized data collection and monitoring of wound progression.

An initiative of such breadth and rigor dedicated to diabetic foot ulcer research is unprecedented, says Patrick Cheng, CEO of eKare. eKare is honored to have been selected by NIDDK and join the Diabetic Foot Consortium to help spearhead breakthrough advancements in DFU research.

About eKareeKare Inc. is dedicated to the design and development of wound assessment solutions, including 3D wound dimensions and tissue classification capabilities, using the latest computer-vision and mobile technology. eKare's innovative technology is creating new possibilities in how we deliver wound care across the healthcare continuum, from inpatient hospital and skilled nursing facilities to ambulatory clinics and telemedicine. eKare's mission is to advance the science and delivery of wound care by leveraging mobile and sensor technologies to connect patients, providers, and industry.

The content in this release is the sole responsibility of the authors and does not necessarily represent the official views or imply endorsement of the National Institutes of Health.

1. Raghav A, Khan ZA, Labala RK, Ahmad J, Noor S, Mishra BK. Financial burden of diabetic foot ulcers to world: a progressive topic to discuss always. Ther Adv Endocrinol Metab. 2018;9(1):2931. doi:10.1177/2042018817744513.

Share article on social media or email:

Go here to see the original:
eKare joins the NIH-led Diabetic Foot Consortium for Landmark Diabetic Foot Ulcer Research - PR Web